Stars Shine at Beverly Hills Gala by Beauty-Stem: Advancing Health Innovations and Cancer Research

LOS ANGELES, CA / ACCESSWIRE / November 16, 2024 / Today, in the heart of Beverly Hills, Beauty-Stem-a branch of Power-Stem Biomedical-hosted a prestigious gala, bringing together prominent philanthropists and industry leaders in support of cutting-edge stem cell advancements and crucial cancer research alongside the American Cancer Society. High-profile guests like Kathryn Morris and Victoria Summer attended the event, which featured the acclaimed CD34 Nu-Signals®oral stem cell supplement, noted for boosting immune health and cellular renewal, instilling hope in both cancer survivors and those focused on anti-aging.

Victoria Summer & Kathryn Morris

A New Chapter of Health for Kathryn Morris

Renowned actress and dedicated philanthropist Kathryn Morris took the stage to share her personal journey. Known globally for her dramatic roles, Kathryn revealed her challenges as a single mother of autistic twins, a journey that left her feeling physically exhausted. With the support of CD34 Nu-Signals®, she found renewed energy and vitality, enabling her to fully embrace her life as a mother and a leader of “The Savants,” her charity organization. “It’s been transformative,” Kathryn shared, as her story resonated with attendees, underscoring the potential for self-renewal.

Victoria Summer‘s Advocacy for Holistic Wellness

Actress and singer Victoria Summer, who also serves as an ambassador for Teen Cancer America, hosted the evening with a strong message on the importance of balanced health. Recognized for her poise, Victoria spoke about her dedication to natural wellness solutions and the challenges posed by her demanding career. She praised CD34 Nu-Signals® for providing reliable, vegan health support without adverse effects, calling it an “essential part of her daily routine.” Her endorsement added credibility to the supplement’s natural, health-boosting benefits.

Power-Stem Biomedical‘s Groundbreaking Journey

CD34 Nu-Signals® represents over two decades of intensive research led by Dr. Chai-Ching Lin, President of Power-Stem Biomedical. Supported by a distinguished team of experts, Dr. Lin‘s work has achieved FDA certification, bringing hope to those seeking regenerative health solutions. Dr. Sahar Lashin, MD, PhD, founder of IntegrUtopia, joined the discussion, sharing insights on CD34‘s regenerative properties in immune support and tissue repair, marking a new chapter in cancer prevention and age management.

The event’s proceeds will go toward the American Cancer Society, fueling its vital work in cancer prevention, patient care, and research. Through Power-Stem Biomedical‘s steadfast commitment to innovative stem cell research and health advocacy, the organization strives to improve quality of life and advance disease prevention.

Today’s gala reinforced Beauty-Stem Biomedical‘s dedication to global health progress, providing inspiration, hope, and healing to communities worldwide.

Contact Information

Beauty-Stem Marketing
Media Department
marketing@beauty-stem.com
888-341-7505

SOURCE: Beauty-Stem Biomedical US

View the original press release on newswire.com.

Staff

Recent Posts

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

8 hours ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

11 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

11 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

11 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

11 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

11 hours ago